Alkermes (ALKS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Further to the announcement under Rule 2.7 of the Irish Takeover Rules by Avadel and Alkermes on November 19, 2025, Danish ...
In a statement, Denmark-based Lundbeck said it had carried out a "comprehensive assessment" of the bids on the table for ...
This latest corporate clash has Alkermes working to beat back a challenge from H. Lundbeck for sleep disorder drug developer Avadel Pharmaceuticals.
Johnson & Johnson entered into a definitive agreement to acquire Halda Therapeutics OpCo for $3.05 billion in cash. Eli Lilly announced it will pay $40 million upfront and up to $2.56 billion in a ...
Ireland-based Alkermes (Nasdaq: ALKS) has upped its offer to buy Avadel Pharmaceuticals (Nasdaq: AVDL). Under the improved ...
Lundbeck had tried to scoop the narcolepsy drug maker out from under Alkeremes with $2.4 billion, but Avadel has elected to ...
Alkermes ups bid for Avadel as Lundbeck looms; Severe flu season could be on the way for U.S.; Can GLP-1s treat Alzheimer’s?
Alkermes ( (ALKS) ) has shared an announcement. On November 18, 2025, Alkermes plc and Avadel Pharmaceuticals plc amended their transaction agreement, increasing the cash consideration for the ...
Investor's Business Daily on MSN
Alkermes Ups Its Avadel Bid To $2.37 Billion In A Buyout Battle With Lundbeck
Alkermes upped its bid on Avadel to $2.37 billion on Wednesday, coming in with the "superior proposal" vs. Lundbeck's ...
Learn more about whether Alkermes plc or Aurinia Pharmaceuticals Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Electronic Systems Technology, Inc. (OTCMKTS: ELST ) related to its merger with Lifeloc Technologies, Inc. Under the terms of the proposed transaction, each outstanding share of common stock of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results